Willow Biosciences Company Executives
| WLLW Stock | CAD 0.08 0.01 6.67% |
Willow Biosciences employs about 19 people. The company is managed by 7 executives with a total tenure of roughly 45 years, averaging almost 6.0 years of service per executive, having 2.71 employees per reported executive. Analysis of Willow Biosciences' management performance can provide insight into the firm performance.
Willow |
Willow Biosciences Management Team Effectiveness
The company has return on total asset (ROA) of (0.7479) % which means that it has lost $0.7479 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.122) %, meaning that it generated substantial loss on money invested by shareholders. Willow Biosciences' management efficiency ratios could be used to measure how well Willow Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. As of the 11th of December 2024, Return On Tangible Assets is likely to drop to -2.05. In addition to that, Return On Capital Employed is likely to grow to -2.58. At this time, Willow Biosciences' Asset Turnover is very stable compared to the past year.As of the 11th of December 2024, Common Stock Shares Outstanding is likely to grow to about 130.5 M, while Net Loss is likely to drop (14 M).
Willow Biosciences Workforce Comparison
Willow Biosciences is rated third in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 225. Willow Biosciences holds roughly 19.0 in number of employees claiming about 8% of equities under Health Care industry.
Willow Biosciences Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Willow Biosciences Price Series Summation is a cross summation of Willow Biosciences price series and its benchmark/peer.
Willow Biosciences Notable Stakeholders
A Willow Biosciences stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Willow Biosciences often face trade-offs trying to please all of them. Willow Biosciences' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Willow Biosciences' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Chris Savile | Director President | Profile | |
| Sanjib LLB | Corporate Secretary | Profile | |
| Simon Hickling | Sr Devel | Profile | |
| Peter SeuferWasserthal | CEO Pres | Profile | |
| Troy Talkkari | Vice Development | Profile | |
| Travis Doupe | Chief Officer | Profile | |
| Trish Choudhary | Senior Development | Profile |
About Willow Biosciences Management Performance
The success or failure of an entity such as Willow Biosciences often depends on how effective the management is. Willow Biosciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Willow management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Willow management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.95) | (2.05) | |
| Return On Capital Employed | (2.71) | (2.58) | |
| Return On Assets | (1.95) | (2.05) | |
| Return On Equity | (3.79) | (3.60) |
Willow Biosciences Workforce Analysis
Traditionally, organizations such as Willow Biosciences use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Willow Biosciences within its industry.Willow Biosciences Manpower Efficiency
Return on Willow Biosciences Manpower
| Revenue Per Employee | 61.7K | |
| Revenue Per Executive | 167.4K | |
| Net Loss Per Employee | 685.7K | |
| Net Loss Per Executive | 1.9M | |
| Working Capital Per Employee | 124.2K | |
| Working Capital Per Executive | 337K |
Other Information on Investing in Willow Stock
Willow Biosciences financial ratios help investors to determine whether Willow Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Willow with respect to the benefits of owning Willow Biosciences security.